The AKT inhibitor, MK-2206, attenuates ABCG2-mediated drug resistance in lung and colon cancer cells

• Egile Nagusiak: Hai-Ling Gao (Egilea), Qingbin Cui (Egilea), Jing-Quan Wang (Egilea), Charles R. Ashby (Egilea), Yanchun Chen (Egilea), Zhi-Xin Shen (Egilea), Zhe-Sheng Chen (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2023-07-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Introduction: The overexpression of ATP-binding cassette (ABC) transporters, ABCB1 and ABCG2, are two of the major mediators of multidrug resistance (MDR) in cancers. Although multiple ABCB1 and ABCG2 inhibitors have been developed and some have undergone evaluation in clinical trials, none have bee...